 |
 |
|
|
RESÚMENES SEPTIEMBRE 2007 |
Psychotic Disorders
& Antipsychotics
(Haga un click en la información del journal para acceder al resúmen)
5 –
doble-ciego o metanálisis; 4 – subanálisis
o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión
4 - Adjunctive
Treatment With a Dopamine Partial Agonist, Aripiprazole, for Antipsychotic-Induced Hyperprolactinemia: A
Placebo-Controlled Trial
Joo-Cheol Shim,
Jae-Goo K. Shin, Deanna L. Kelly, Do-Un Jung, Young-Soo Seo,
Kwang-Hyeon Liu, Ji-Hong
Shon, and Robert R. Conley
Am J Psychiatry
164:1404-1410, September 2007
3 -
Clozapine Underutilization and Discontinuation in
African Americans Due to Leucopenia
Deanna L. Kelly, Julie Kreyenbuhl, Lisa Dixon,
Raymond C. Love, Deborah Medoff and Robert R. Conley
Schizophrenia Bulletin 2007
33(5):1221-1224
4 -
Pre-treatment, baseline, and outcome differences between early-onset and
adult-onset psychosis in an epidemiological cohort of 636 first-episode
patients
Benno G. Schimmelmann, Philippe Conus,
Sue Cotton, Patrick D. McGorry and Martin Lambert
Schizophrenia
Research.
Volume 95, Issues 1-3, September 2007, Pages 1-8
3 -
Empirical validation of competing definitions of schizophrenia. A
poly-diagnostic study of cognitive impairment in non-affective psychosis
Manuel J. Cuesta, Victor Peralta and Amalia Zarzuela
Schizophrenia
Research.
Volume 95, Issues 1-3, September 2007, Pages 39-47
3 -
Duration of untreated psychosis and neuropsychological function in first
episode psychosis
Julia M. Lappin, Kevin D. Morgan, Craig Morgan, Paola Dazzan, Abraham Reichenberg, Jolanta W. Zanelli, Paul Fearon, Peter B. Jones, Tuhina
Lloyd, Jane Tarrant, Annette Farrant, Julian Leff and Robin M. Murray
Schizophrenia
Research.
Volume 95, Issues 1-3, September 2007, Pages 103-110
3! -
Acute psychosis leads to increased QT variability in patients suffering from
schizophrenia
Karl-Jürgen Bär, Mandy Koschke, Michael Karl Boettger,
Sandy Berger, Alexander Kabisch, Heinrich Sauer,
Andreas Voss and Vikram K. Yeragani
Schizophrenia
Research.
Volume 95, Issues 1-3, September 2007, Pages 115-123
5< -
Effects of olanzapine, risperidone
and haloperidol on prepulse inhibition in
schizophrenia patients: A double-blind, randomized controlled trial
Jonathan K. Wynn,
Michael F. Green, Joyce Sprock, Gregory A. Light,
Clifford Widmark, Christopher Reist,
Stephen Erhart, Stephen R. Marder,
Jim Mintz and David L. Braff
Schizophrenia
Research.
Volume 95, Issues 1-3, September 2007, Pages 134-142
4 -
Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks
John M. Kane,
David T. Crandall, Ronald N. Marcus, James Eudicone,
Andrei Pikalov III, William H. Carson and Wim Swyzen
Schizophrenia
Research.
Volume 95, Issues 1-3, September 2007, Pages 143-150
5< -
Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind,
randomized controlled study
Radovan Prikryl, Tomas Kasparek, Simona Skotakova, Libor Ustohal, Hana Kucerova
and Eva Ceskova
Schizophrenia
Research.
Volume 95, Issues 1-3, September 2007, Pages 151-157
5 -
Effect of buspirone, a serotonin1A partial
agonist, on cognitive function in schizophrenia: A randomized, double-blind,
placebo-controlled study
Tomiki
Sumiyoshi,
Schizophrenia
Research.
Volume 95, Issues 1-3, September 2007, Pages 158-168
3 -
Decreased levels of plasma glutamate in patients with first-episode
schizophrenia and bipolar disorder
Aitor Palomino, Ana González-Pinto, Ana Aldama, Cristina González-Gómez, Fernando Mosquera, Gixane González-García and Carlos
Matute
Schizophrenia
Research.
Volume 95, Issues 1-3, September 2007, Pages 174-178
3! -
Mortality among persons with schizophrenia in
Björn Milesson
Fors; Dag Isacson; Kerstin Bingefors;
Birgitta Widerlöv
Nordic Journal of
Psychiatry, Volume 61, Issue 4 2007 , pages 252 - 259
3> -
Relationships Among Subjective and Objective Measures
of Adherence to Oral Antipsychotic Medications
Dawn I. Velligan, Mei Wang, Pamela Diamond,
David C. Glahn, Desiree Castillo, Scott Bendle, Y. W. Francis Lam, Larry Ereshefsky,
and Alexander L. Miller
Psychiatr
Serv 58:1187-1192, September 2007
3 -
Evaluating the cost-effectiveness of reduced tardive dyskinesia with second-generation antipsychotics
R. A. Rosenheck
The British Journal of Psychiatry (2007) 191:
238-245
1 - Thioridazine:
resurrection as an antimicrobial agent?
H. K. R. Thanacoody
British Journal of Clinical Pharmacology Sep. 2007; OnlineEarly Articles
3 -
Antipsychotics dosage and antiparkinsonian
prescriptions
Eric Acquaviva, Isabelle Gasquet
and Bruno Falissard
Clinical
Practice and Epidemiology in Mental Health 2007, 3:14
TEXTO
GRATUITO
4! - Changes in serum lipids,
independent of weight, are associated with changes in symptoms during long-term
clozapine treatment
Ric M. Procyshyn, Kishor M. Wasan, Allen E.
Thornton, Alasdair M. Barr, Eric Y.H. Chen, Edith Pomarol-Clotet,
Emmanuel Stip, Richard Williams, G. William MacEwan, C. Laird Birmingham, William G. Honer, for the Clozapine and Risperidone Enhancement Study Group
J Psychiatry Neurosci 2007;32(5):331-8
TEXTO
GRATUITO
3! -
Cognitive alterations
in groups at risk for psychosis: neutral markers of genetic risk or indicators
of social disability?
N. Jabben, J. van Os, I. Janssen, D. Versmissen,
L. Krabbendam
Acta Psychiatrica
Scandinavica 2007; 116 (4), 253–262
5< - A placebo-controlled,
random-assignment, parallel-group pilot study of adjunctive topiramate
for patients with schizoaffective disorder, bipolar type
Roy Chengappa, David J Kupfer,
Haranath Parepally, Vineeth John, Ranita Basu, Joan Buttenfield, Patricia Schlicht, Patricia Houck, Jaspreet
S Brar, Samuel Gershon
Bipolar Disorders 9 (6),
609–617
3 - Estrogen, menstrual cycle phases, and
psychopathology in women suffering from schizophrenia
NIELS
BERGEMANN, PETER PARZER, BENNO RUNNEBAUM, FRANZ RESCH and CHRISTOPH MUNDT
Psychological
Medicine, Volume 37, Issue 10, October 2007, pp 1427-1436
2> -
The effects of childhood trauma in patients with first-episode schizophrenia
A. Üçok,
Acta Psychiatrica
Scandinavica (OnlineEarly
Articles). Sep
2007
Egger,
Christoph; Muehlbacher, Moritz; Schatz, Melanie; Nickel, Marius
Journal of Clinical Psychopharmacology.
27(5):475-478, October 2007
3! - Antipsychotic
drugs as a risk factor for venous thromboembolism
Ji
í Masopust;
Radovan Malý; Ale
Urban; Ladislav Hosák;
Eva 
ermáková
International
Journal of Psychiatry in Clinical Practice, Volume 11, Issue 3 2007, pages 246
- 249 3< - The "Seroquel"
Outcomes Study (SOS): Efficacy and tolerability of quetiapine
in a long-term, naturalistic study of patients with schizophrenia Juan Gibert; José Giner; Julio Bobes; Mónica Tafalla; Santiago Herranz; Carmen Ovejero;
Fernando Rico-Villademoros; for the SOS GROUP - See
Appendix for the complete list of SOS Group members International
Journal of Psychiatry in Clinical Practice, Volume 11, Issue 3 2007, pages 222
- 232 3< - Experience with risperidone
long-acting injection: results of a naturalistic observation study Paul N. Deslandes; Arwel Thomas; Gwawr M. Faulconbridge; Wendy C.
Davies International
Journal of Psychiatry in Clinical Practice, Volume 11, Issue 3 2007, pages 207
- 211 3 - Pharmacological strategies for relapse prevention in
schizophrenia Thomas R.E. Barnes and Richard
Drake Psychiatry. Volume 6, Issue 9,
September 2007, Pages 351-356 3< - Antipsychotic Drugs Exacerbate Impairment on a Working
Memory Task in First-Episode Schizophrenia James L. Reilly, Margret S.H. Harris,
Tin T. Khine, Matcheri S. Keshavan and John A. Sweeney Biological Psychiatry. Volume 62, Issue 7, 1
October 2007, Pages 818-821 3 - Clinical evaluation of negative symptoms in schizophrenia Hans-Jürgen
Möller European
Psychiatry. Volume
22, Issue 6, September 2007, Pages 380-386 3 - Differential Effects of Aripiprazole
on D2, 5-HT2, and 5-HT1A Receptor Occupancy in
Patients With Schizophrenia: A Triple Tracer PET Study David Mamo, Ariel Graff, Romina Mizrahi, C. M. Shammi, Françoise Romeyer, and Shitij Kapur Am J Psychiatry 164:1411-1417, September 2007 3! - The relationship between the
therapeutic response to risperidone and the dopamine
D2 receptor polymorphism in Chinese schizophrenia patients Qinghe Xing, Xueqing
Qian, Huafang Li, Shiming Wong, Shengnan Wu, Guoyin Feng, Shiwei
Duan, Mingqing Xu, Rui Gao,
Wei Qin, Jianjun Gao, Junwei Meng and Lin He The
International Journal of Neuropsychopharmacology,
Volume 10, Issue 05, October 2007, pp 631-637 3< - Association
study of tardive dyskinesia
and twelve DRD2 polymorphisms in schizophrenia patients Clement C. Zai,
Rudi W. Hwang, Vincenzo De Luca, Daniel J. Müller, Nicole King, Gwyneth C. Zai,
Gary Remington, Herbert Y. Meltzer, Jeffrey A. Lieberman, Steven G. Potkin and James L. Kennedy The
International Journal of Neuropsychopharmacology,
Volume 10, Issue 05, October 2007, pp 639-651 3 - A comparative study of the plasma
membrane permeabilization and fluidization induced by
antipsychotic drugs in the rat brain Tetsuhito Murata, Nobuyuki Maruoka, Naoto Omata, Yasuhiro
Takashima, Yasuhisa Fujibayashi, Yoshiharu Yonekura
and Yuji Wada The
International Journal of Neuropsychopharmacology,
Volume 10, Issue 05, October 2007, pp 683-689 5 - Association of the HTR2C gene and
antipsychotic induced weight gain: a meta-analysis Vincenzo De Luca, Daniel J. Mueller,
Andrea de Bartolomeis and James L. Kennedy The
International Journal of Neuropsychopharmacology,
Volume 10, Issue 05, October 2007, pp 697-704 3 - Choline acetyltransferase variants and their influence in
schizophrenia and olanzapine response D. Mancama, 3 - Antipsychotic drugs reverse the disruption
in prefrontal cortex function produced by NMDA receptor blockade with
phencyclidine Lucila Kargieman, Noemí Santana,
Guadalupe Mengod, PNAS | September 11,
2007 | vol. 104 | no. 37 | 14843-14848
3 - Clozapine and Haloperidol
Differently Suppress the MK-801-Increased Glutamatergic
and Serotonergic Transmission in the Medial
Prefrontal Cortex of the Rat Xavier López-Gil,
Zoila Babot, Mercè Amargós-Bosch,
Cristina Suñol, Francesc Artigas
and Albert Adell Neuropsychopharmacology (2007) 32, 2087–2097 3< - The
Influence of Antipsychotic Treatment on Brain Reward System Reactivity in
Schizophrenia Patients P. Kirsch,
S. Ronshausen, D. Mier, B. Gallhofer Pharmacopsychiatry 2007;
40: 196-198 3 - Protective effect
of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial
dyskinesia and associated behavioural, biochemical and neurochemical changes 3 - Subjective response and attitudes toward antipsychotic
drug therapy during the initial treatment period: a prospective follow-up study
in patients with schizophrenia 3! - Atypical antipsychotics attenuate
a sub-chronic PCP-induced cognitive deficit in the novel object recognition
task in the rat B. Grayson, N.F. Idris
and J.C. Neill Behavioural Brain Research. Volume 184, Issue 1, 22
November 2007, Pages 31-38 3! - Risk of Treatment-Emergent Diabetes Mellitus in Patients
Receiving Antipsychotics Leslie L Citrome, Richard IG Holt, Woodie
M Zachry, Jerry D Clewell,
Paul A Orth, Jamie L Karagianis,
Vicki The
Annals of Pharmacotherapy: Vol. 41, No. 10, pp. 1593-1603 3! - Characterization and Clinical Management of Clozapine-Induced Fever Carolina
TEXTO GRATUITO
Mahendra
Bishnoi, Kanwaljit Chopra, Shrinivas K. Kulkarni
Fundamental & Clinical Pharmacology 2007; 21 (5),
521–529
A. Hofer, M. A. Rettenbacher, M.
Edlinger, G. Kemmler, C. G. Widschwendter, W. W. Fleischhacker
Acta
Psychiatrica Scandinavica (OnlineEarly Articles) Oct 2007
The
Annals of Pharmacotherapy: Vol. 41, No. 10, pp. 1700-1704
3 - Association study of olanzapine-induced
weight gain and therapeutic response with SERT gene polymorphisms in female
schizophrenic patients
Nada Bozina, Vesna Medved,
Martina Rojnic Kuzman, Ivica Sain, Jadranka
Sertic
Journal of
Psychopharmacology, Vol. 21, No. 7, 728-734 (2007)
3 - Olanzapine prolongs cardiac repolarization by blocking the rapid component of the
delayed rectifier potassium current
Pierre Morissette, Raymond Hreiche,
Louise Mallet, Dean Vo, Edward E. Knaus, Jacques
Turgeon
Journal of
Psychopharmacology, Vol. 21, No. 7, 735-741 (2007)
3! - Placental transfer of quetiapine
in relation to P-glycoprotein activity
Melissa Rahi, Tuija Heikkinen,
Sebastian Härtter, Jukka Hakkola, Kristo Hakala, Ola Wallerman, Mia Wadelius, Claes Wadelius, Kari Laine
Journal of
Psychopharmacology, Vol. 21, No. 7, 751-756 (2007)
3 - Prevalence of hyperprolactinaemia
in a naturalistic cohort of schizophrenia and bipolar outpatients during
treatment with typical and atypical antipsychotics
Chris Bushe, Michael Shaw
Journal of
Psychopharmacology, Vol. 21, No. 7, 768-773 (2007)
3! - Individualizing Antipsychotic Drug Therapy in
Schizophrenia: The Promise of Pharmacogenetics
Charles U. Nnadi and Anil K. Malhotra
Current Psychiatry Reports 2007, 9:313-318
TEXTO GRATUITO
3 - Early Intervention in Schizophrenia: Current and Future
Perspectives
Matcheri S. Keshavan
and Ali Amirsadri
Current Psychiatry Reports 2007, 9:325-328
TEXTO GRATUITO
3! - Reducing Variation in the Pharmacologic Treatment of
Schizophrenia: Defining Acceptable Standards of Treatment
